Lithium dosage and leukocyte counts in psychiatric patients

Journal of Psychiatry and Neuroscience

Volumn 24, Issue 3, 1999, Pages 215-221

  Oyewumi, L Kola ^a,b   McKnight, Maryanne ^c   Cernovsky, Zack Z ^c  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b London Psychiatric Hospital   (Canada)

^c NONE

Author keywords

Antipsychotic agents; Blood cell count; Blood cells; Dozapine; Granulocytes; Leukocyte count; Leukocytes; Leukocytosis; Leukopenia; Lithium; Lymphocyte count

Indexed keywords

CHLORPROMAZINE; CLOZAPINE; FLUPENTIXOL; FLUPHENAZINE; HALOPERIDOL; LEVOMEPROMAZINE; LITHIUM; LOXAPINE; NEUROLEPTIC AGENT; PERPHENAZINE; RISPERIDONE; TRIFLUOPERAZINE;

ARTICLE; FEMALE; GRANULOCYTE; HUMAN; LEUKOCYTE; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTIPSYCHOTIC AGENTS; CHI-SQUARE DISTRIBUTION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LEUKOCYTE COUNT; LEUKOCYTES; LEUKOPENIA; LITHIUM; MALE; MENTAL DISORDERS; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 0033067547     PISSN: 11804882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Balon R, Berchou R. Haematological side effects of psychotropic drugs. Psychosomatics 1986;27:119-27.
2. Kramlinger KG, Post RM. Addition of lithium carbonate to carbamazepine: haematological and thyroid effects. Am J Psychiatry 1990;147:615-20.
3. Brewerton TD. Lithium counteracts carbamazepine-induced leucopenia while increasing its therapeutic effect. Biol Psychiatry 1986;21:677-85.
4. Adityanjee. Modification of clozapine-induced leucopenia and neutropenia with lithium carbonate [letter]. Am J Psychiatry 1995;152:648-9.
5. Oyewumi LK. Efficacy of lithium in treating severe clozapine-induced leucopenia and neutropenia [abstract]. 21st Annual Meeting of the Canadian College of Neuropsychopharmacology, Montreal, 14-17 June 1998.
6. Silverstone PH. Prevention of clozapine-induced neutropenia by pretreatment with lithium [letter]. J Clin Psychopharmacol 1998;18:86-8.
7. Yassa R, Ananth J. Treatment of neuroleptic induced leucopenia with lithium carbonate. Can J Psychiatry 1981;26:487-90.
8. Ozdemir MA, Sofuoghi S, Tamrikilu G, Aldanmaz F, Esel E, Dunbar S. Lithium-induced haematologic changes in patients with bipolar affective disorder. Biol Psychiatry 1994;35:210-3.
9. Sandoz Canada. Clozafil product monograph. Dorval, Quebec: Sandoz; 1992.
10. Pope HG Jr, Cole JO, Choras PT, Fulwiler CE. Aparent neuroleptic malignant syndrome with clozapine and lithium. J Nerv Ment Dis 1986;174:493-5.
11. Valevski A, Lahav MM, Weizman A. Clozapine-lithium combined treatment and agranulocytosis. Int Clin Psychopharmacol 1993;8:63-5.
12. Thornberg SA, Ereshefsky L. Neuroleptic malignant syndrome associated with clozapine monotherapy. Pharmacotherapy 1993;13:510-4.
13. Weller M, Kornhuber J. Clozapine rechallenge after an episode of 'neuroleptic malignant syndrome'. Br J Psychiatry 1992;161: 855-6.
14. Tisman G, Herbert V, Rosenblatt S. Evidence that lithium induces human granulocyte proliferation: elevated serum vitamin B12 binding capacity in vivo and granulocyte colony proliferation in vitro. Br J Haematol 1973;24:767-71.
15. Morley DC, Galbraith PR. Effect of lithium on granulopoiesis in culture. CMAJ 1998;118:288.
16. Lieberman JA, Kane JM, Johns CA. Clozapine: guidelines for clinical management. J Clin Psychiatry 1989;50:329-38.